Nestlé
Search results
At Galderma, we embrace these differences and offer cutting-edge, premium brands that fit people's individual needs, across the full spectrum of dermatology through Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. LEARN MORE.
Galderma is the pure-play dermatology category leader, committed to advancing dermatology for every skin story. Leveraging our unique 40-year heritage of leading science-based innovation, we deliver a synergistic portfolio of flagship brands and services that span the full spectrum of dermatology.
Galderma is the leading company solely dedicated to the body’s largest organ: the skin. We are strategically positioned in resilient, highly attractive and consumer-focused sub-segments of Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology.
Galderma S.A. is a Swiss pharmaceutical company specializing in dermatological treatments and skin care products. Formerly a subsidiary of L'Oréal and Nestlé , it has been held by a consortium of private institutional investors since 2019.
2 days ago · Commercial performance. Galderma achieved record net sales of 2.2 billion USD for the first half of 2024, representing 10.8% year-on-year net sales growth on a constant currency basis, predominantly driven by volume complemented by favorable mix.. Performance in the first half of the year was underpinned by continued execution of Galderma’s growth-focused integrated dermatology strategy and its three strategic pillars, including new launches and progress on its two biologic candidates with ...
The Investor Relations website contains information about Galderma's business for stockholders, potential investors, and financial analysts.
3 days ago · Galderma Group AG, the pure-play dermatology category leader, today announced its financial results for the first half of 2024. “Galderma delivered a strong first half of the year with excellent ...
2 days ago · Galderma , opens new tab posted net sales in the January-June period of $2.2 billion, up 10.8% on a constant currency basis, as Core EBITDA (earnings before interest, tax, depreciation and ...
Galderma | 362,058 followers on LinkedIn. We are advancing dermatology for every skin story | Galderma is the leading company solely dedicated to skin and advancing the future of dermatology.
The mission of Galderma is to enhance people’s quality of life and contribute to a healthier future through science-based solutions for skin health.
